Plant Based Bioreactors of Recombinant Cytokines (Review)

Area of Science:

• Biotechnology
• Immunology
• Pharmacology

Background:

• Cytokines are crucial signaling polypeptides regulating immune responses and physiological functions.
• Current therapeutic applications of cytokines for cancer, immune disorders, and viral infections are limited by high production costs.

Purpose of the Study:

• To review recent advancements in producing cytokines using genetically modified plants.
• To highlight the potential of plant-based biotechnology in overcoming cytokine production cost barriers.

Main Methods:

• Review of scientific literature on genetic engineering and plant biotechnology for protein production.
• Analysis of methods for producing various cytokines in transgenic plants.

Main Results:

• Genetically modified plants can produce significant quantities of therapeutic proteins, including cytokines.
• Plant-based production offers a potentially more economical alternative to traditional methods.

Conclusions:

• Transgenic plants represent a promising platform for the cost-effective production of cytokines.
• Advancements in genetic engineering are expanding the therapeutic potential of cytokines by improving accessibility.